https://doi.org/10.55788/1d6a06b7
“pRNFL and GCIPL have not been studied as predictors of disability accumulation in newly diagnosed RMS and within the framework of known baseline demographic, clinical, and radiological risk factors,” said Prof. Gabriel Bsteh (Medical University of Vienna, Austria). He presented the results of a study that included patients from whom a spectral-domain OCT scan was obtained within 90 days after RMS diagnosis [1,2]. Follow-up was at least 12 months and the primary endpoint was time to disability accumulation, defined as a confirmed Expanded Disability Status Scale (EDSS) score ≥3.0.
The analysed study cohort consisted of 231 MS patients. The mean age was 30.3 years, 74% were women, and the mean time to diagnosis was 45 days. The mean number of T2 lesions on baseline MRI was 11 (range 0–45). Baseline mean pRNFL and GCIPL thickness were 91.9 µm and 80.2 µm, respectively. The median follow-up was 61 months (range 12–93). EDSS ≥3.0 was reached by 28 patients (12.1%) after a median of 49 months (range 9–92).
Reaching EDSS ≥3.0 was predicted by pRNFL thickness ≤88 µm (HR 4.0; 95% CI 1.8–3.3; P<0.001) and by GCIPL thickness <77 µm (HR 5.1; 95% CI 1.6–4.2; P<0.001). Time to progression independent of relapse activity (PIRA) was also predicted by pRNFL thickness ≤88 µm (HR 3.1; 1.7–5.4; P<0.001) and by GCIPL thickness <77 µm (HR 4.1; 95% CI 2.3–7.3; P<0.001). Prof. Bsteh said it was “very encouraging” to see that this was independent of other important risk factors, such as age, MRI lesion load, and DMT use. PRFNL and GCIPL thickness did not predict inflammatory activity, measured by time to second clinical relapse.
Prof. Bsteh concluded that pRNFL/GCIPL thickness may be a cross-sectional marker of neuro-axonal damage and could potentially inform treatment strategy. However, availability of OCT is limited and it requires quality control. Prof. Bsteh also pointed out that changes in retinal layer thickness are not specific to MS, but can be influenced by other factors, including diabetes mellitus and glaucoma. Moreover, OCT is not applicable if there is myopia of >4–6 diopters or retinal comorbidities.
- Bsteh G, et al. Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis. EAN 2023 Annual Meeting, 1–4 July, Budapest, Hungary.
- Bsteh G, et al. Eur J Neurol. 2023;30(4):1025–1034.
Copyright ©2023 Medicom Medical Publishers
Posted on
Previous Article
« Withdrawing DMF in early pregnancy does not increase relapse risk in pregnant patients with MS Next Article
Which patients can initially be treated with platform DMT? »
« Withdrawing DMF in early pregnancy does not increase relapse risk in pregnant patients with MS Next Article
Which patients can initially be treated with platform DMT? »
Table of Contents: EAN 2023
Featured articles
Letter from the Editor
Alzheimer’s disease and dementia: the road towards proactive and preventive care
Overarching Theme: Big Data
Contribution of genomics and genetics to personalised medicine
How big data can boost care for neurodegenerative disorders
COVID-19
Amantadine in early COVID-19 enhances recovery
SARS-CoV-2 vaccination in CIDP and MMN: more benefit than harm
Cerebrovascular Disease and Stroke
Intensive BP reduction associated with smaller haematoma
Cognition and Dementia
Towards cell biology of Alzheimer’s disease
Epilepsy
Minimising co-medication optimises cenobamate efficacy in drug-resistant epilepsy
Headache and Pain
GLP-1 agonists induce weight loss and alleviate headache in idiopathic intracranial hypertension
Cannabis-based medicine does not beat placebo in central neuropathic pain
80% of patients reverse from chronic to episodic migraine on anti-CGRP antibodies
Multiple Sclerosis
Which patients can initially be treated with platform DMT?
Retinal layer thickness predicts disability accumulation in early RMS
Withdrawing DMF in early pregnancy does not increase relapse risk in pregnant patients with MS
Immunosenescence and MS: relevance to immunopathogenesis and treatment
Sleep Disorders
Nightmares during childhood linked to cognitive decline later in life
Sleep changes contribute to the pathogenesis of neurodegenerative diseases
Miscellaneous
EAN guidelines on the management of ALS
What neurologists should know about bladder and sexual problems
Laughing gas abuse often leads to polyneuropathy, myelopathy, and encephalopathy
Related Articles
September 7, 2023
What neurologists should know about bladder and sexual problems
September 7, 2023
EAN guidelines on the management of ALS
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy